Charlie currently serves as Senior Vice President, Corporate Strategy and Business Development for Boston Scientific. He joined the company in 2010 and his team is responsible for corporate strategic planning as well as coordinating the identification, assessment and execution of business development transactions including acquisitions, VC/minority investments, divestitures, licensing deals, co-development agreements and joint ventures. Boston Scientific has been amongst the most active investors in medical technology over the past 8 years, having completed over 30 acquisitions across size ranges from sub $10M to over $1B, as well as growing our venture capital portfolio to over 30 investments across strategic areas of interest. Charlie received a BA in Economics from Princeton University.